Northern Trust’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-769,094
| Closed | -$32.4M | – | 4545 |
|
|
2023
Q2 | $32.4M | Sell |
769,094
-423,703
| -36% | -$17.1M | 0.01% | 1250 |
|
|
2023
Q1 | $42.5M | Buy |
1,192,797
+222,368
| +23% | +$8.07M | 0.01% | 1061 |
|
|
2022
Q4 | $35.6M | Buy |
970,429
+5,845
| +0.6% | +$231K | 0.01% | 1150 |
|
|
2022
Q3 | $45.5M | Sell |
964,584
-11,215
| -1% | -$724K | 0.01% | 919 |
|
|
2022
Q2 | $69.9M | Buy |
975,799
+17,890
| +2% | +$1.31M | 0.02% | 696 |
|
|
2022
Q1 | $77.5M | Sell |
957,909
-17,498
| -2% | -$1.48M | 0.01% | 757 |
|
|
2021
Q4 | $100M | Sell |
975,407
-7,670
| -0.8% | -$737K | 0.02% | 664 |
|
|
2021
Q3 | $86M | Sell |
983,077
-7,638
| -0.8% | -$691K | 0.02% | 722 |
|
|
2021
Q2 | $88.7M | Buy |
990,715
+142,577
| +17% | +$12M | 0.02% | 732 |
|
|
2021
Q1 | $64.3M | Buy |
848,138
+98,583
| +13% | +$7.43M | 0.01% | 921 |
|
|
2020
Q4 | $51.1M | Buy |
749,555
+39,162
| +6% | +$2.44M | 0.01% | 1065 |
|
|
2020
Q3 | $37.8M | Buy |
710,393
+25,345
| +4% | +$1.51M | 0.01% | 1110 |
|
|
2020
Q2 | $39.9M | Sell |
685,048
-469,882
| -41% | -$25.3M | 0.01% | 1061 |
|
|
2020
Q1 | $45.5M | Buy |
1,154,930
+4,727
| +0.4% | +$276K | 0.01% | 830 |
|
|
2019
Q4 | $68.4M | Sell |
1,150,203
-7,998
| -0.7% | -$430K | 0.02% | 796 |
|
|
2019
Q3 | $61.6M | Buy |
1,158,201
+28,207
| +2% | +$1.45M | 0.01% | 825 |
|
|
2019
Q2 | $57.7M | Sell |
1,129,994
-31,420
| -3% | -$1.46M | 0.01% | 894 |
|
|
2019
Q1 | $60.1M | Buy |
1,161,414
+14,659
| +1% | +$711K | 0.01% | 828 |
|
|
2018
Q4 | $45.1M | Buy |
1,146,755
+6,436
| +0.6% | +$299K | 0.01% | 936 |
|
|
2018
Q3 | $58.8M | Buy |
1,140,319
+103,674
| +10% | +$5.08M | 0.01% | 876 |
|
|
2018
Q2 | $48.6M | Sell |
1,036,645
-7,695
| -0.7% | -$319K | 0.01% | 1029 |
|
|
2018
Q1 | $37.1M | Buy |
1,044,340
+275,956
| +36% | +$10.8M | 0.01% | 1223 |
|
|
2017
Q4 | $33.5M | Sell |
768,384
-108,439
| -12% | -$5.07M | 0.01% | 1315 |
|
|
2017
Q3 | $45.9M | Sell |
876,823
-14,071
| -2% | -$785K | 0.01% | 1030 |
|
|
2017
Q2 | $52.1M | Buy |
890,894
+337,707
| +61% | +$17.5M | 0.01% | 896 |
|
|
2017
Q1 | $25.4M | Buy |
553,187
+8,696
| +2% | +$433K | 0.01% | 1472 |
|
|
2016
Q4 | $28.6M | Buy |
544,491
+23,684
| +5% | +$1.15M | 0.01% | 1320 |
|
|
2016
Q3 | $23.2M | Buy |
520,807
+38,696
| +8% | +$1.68M | 0.01% | 1474 |
|
|
2016
Q2 | $18.4M | Buy |
482,111
+264,593
| +122% | +$11.6M | 0.01% | 1595 |
|
|
2016
Q1 | $8.95M | Buy |
217,518
+23,765
| +12% | +$979K | ﹤0.01% | 2047 |
|
|
2015
Q4 | $9.4M | Buy |
193,753
+26,704
| +16% | +$1.19M | ﹤0.01% | 2053 |
|
|
2015
Q3 | $6.68M | Buy |
167,049
+59,804
| +56% | +$2.61M | ﹤0.01% | 2263 |
|
|
2015
Q2 | $4.3M | Buy |
107,245
+13,041
| +14% | +$450K | ﹤0.01% | 2611 |
|
|
2015
Q1 | $3.08M | Buy |
94,204
+872
| +0.9% | +$24.1K | ﹤0.01% | 2831 |
|
|
2014
Q4 | $2.4M | Buy |
+93,332
| New | +$2.22M | ﹤0.01% | 2990 |
|
Other funds holding SYNH
IA
BTI
CFB
HNB
Northern Trust's SYNH Position: Q3 2023 in Review
Northern Trust sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 769,094 shares — an estimated $32.4M sold.
Northern Trust first reported a position in SYNH in Q4 2014 and held it in 35 quarters. The position peaked at $100M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- Northern Trust reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- Northern Trust sold 769,094 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $32.4M.
- Northern Trust first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 35 quarters.
- Northern Trust's Syneos Health, Inc. Class A Common Stock position peaked at $100M in Q4 2021.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.